Unlocking the genetics of skin cancer
12 de nov. de 2024 ·
11m 4s
Descarga y escucha en cualquier lugar
Descarga tus episodios favoritos y disfrútalos, ¡dondequiera que estés! Regístrate o inicia sesión ahora para acceder a la escucha sin conexión.
Descripción
Dr https://www.sanger.ac.uk/person/adams-david/, Senior Group Leader at the Wellcome Sanger Institute, is a pioneer in cancer biology and uncovering skin cancer genetics. We explore his 20-year career at Sanger and the...
mostra más
Dr David Adams, Senior Group Leader at the Wellcome Sanger Institute, is a pioneer in cancer biology and uncovering skin cancer genetics. We explore his 20-year career at Sanger and the global impact of his research.
Melanoma is the fifth most common cancer in the UK, and while treatments have progressed in recent years, it is still the deadliest form of skin cancer. Dave Adams leads a team at the Sanger Institute that study a range of cancer types, with a focus on melanoma. His work has created a foundational understanding of cancer genetics and the results hold promise for new treatments. Dave has recently been promoted to Interim Head of the Cancer, Ageing and Somatic Mutation research programme at the Sanger Institute.
mostra menos
Melanoma is the fifth most common cancer in the UK, and while treatments have progressed in recent years, it is still the deadliest form of skin cancer. Dave Adams leads a team at the Sanger Institute that study a range of cancer types, with a focus on melanoma. His work has created a foundational understanding of cancer genetics and the results hold promise for new treatments. Dave has recently been promoted to Interim Head of the Cancer, Ageing and Somatic Mutation research programme at the Sanger Institute.
Información
| Autor | Wellcome Sanger Institute |
| Organización | Wellcome Sanger Institute |
| Página web | - |
| Etiquetas |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
